MHLA

MHLA
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2025 | $14.049M ▲ | $10.773M ▲ | $-8.645M ▲ | -61.535% ▼ | $-0.09 ▼ | $-3.815M ▲ |
| Q4-2024 | $-7.432M ▼ | $-5.164M ▼ | $-157.972M ▼ | 2.126K% ▲ | $0.43 ▲ | $-143.891M ▼ |
| Q3-2024 | $14.477M ▼ | $10.014M ▲ | $-34.468M ▼ | -238.088% ▼ | $-0.35 ▼ | $0 ▼ |
| Q2-2024 | $20.487M ▼ | $7.879M ▼ | $-9.971M ▼ | -48.67% ▼ | $-0.1 ▼ | $3.079M ▼ |
| Q1-2024 | $28.904M | $8.06M | $1.442M | 4.989% | $0.014 | $42.531M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2025 | $44.268M ▲ | $1.235B ▼ | $1.197B ▼ | $37.573M ▼ |
| Q4-2024 | $34.735M ▼ | $1.316B ▼ | $1.271B ▲ | $45.193M ▼ |
| Q3-2024 | $127.788M ▲ | $1.394B ▼ | $1.185B ▲ | $208.182M ▼ |
| Q2-2024 | $24.807M ▲ | $1.4B ▲ | $1.162B ▲ | $238.046M ▼ |
| Q1-2024 | $20.721M | $899.625M | $650.265M | $249.36M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2025 | $-8.645M ▲ | $-21.126M ▲ | $29.477M ▲ | $0 ▲ | $9.16M ▲ | $-21.126M ▲ |
| Q4-2024 | $-167.367M ▼ | $-48.293M ▼ | $-29.334M ▼ | $-602K ▲ | $-79.704M ▼ | $-110.041M ▼ |
| Q3-2024 | $-36.52M ▼ | $-3.824M ▼ | $94.424M ▲ | $-641K ▲ | $90.466M ▲ | $26.494M ▲ |
| Q2-2024 | $1.459M | $8.049M | $-19.736M | $-673K | $-12.508M | $8.049M |
| Q1-2024 | $1.459M | $8.049M | $-19.736M | $-673K | $-12.508M | $8.049M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, the historical financial record shows a company that has struggled with profitability, shrinking assets, and persistent negative cash flow, leaving a thinner capital base and limited financial flexibility. At the same time, the strategic pivot into Kestrel Group represents a clean break with the past and a move toward a more modern, capital‑light, fee‑oriented specialty insurance model. The new structure, carrier partnerships, and experienced leadership create potential for a more stable and scalable earnings profile, but this remains largely unproven. From here, the key questions are whether the new model can generate steady fee income, improve cash generation, and rebuild financial strength while successfully differentiating itself in the competitive specialty insurance ecosystem.
About Maiden Holdings, Ltd. 6.625 NT 2046
http://www.maiden.bmMaiden Holdings Ltd. engages in the provision of non-catastrophic, customized reinsurance products and services to small and mid-size insurance companies. It operates through the Diversified Reinsurance and AmTrust Reinsurance segments. The Diversified Reinsurance segment consists of a portfolio of property and casualty reinsurance business.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2025 | $14.049M ▲ | $10.773M ▲ | $-8.645M ▲ | -61.535% ▼ | $-0.09 ▼ | $-3.815M ▲ |
| Q4-2024 | $-7.432M ▼ | $-5.164M ▼ | $-157.972M ▼ | 2.126K% ▲ | $0.43 ▲ | $-143.891M ▼ |
| Q3-2024 | $14.477M ▼ | $10.014M ▲ | $-34.468M ▼ | -238.088% ▼ | $-0.35 ▼ | $0 ▼ |
| Q2-2024 | $20.487M ▼ | $7.879M ▼ | $-9.971M ▼ | -48.67% ▼ | $-0.1 ▼ | $3.079M ▼ |
| Q1-2024 | $28.904M | $8.06M | $1.442M | 4.989% | $0.014 | $42.531M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2025 | $44.268M ▲ | $1.235B ▼ | $1.197B ▼ | $37.573M ▼ |
| Q4-2024 | $34.735M ▼ | $1.316B ▼ | $1.271B ▲ | $45.193M ▼ |
| Q3-2024 | $127.788M ▲ | $1.394B ▼ | $1.185B ▲ | $208.182M ▼ |
| Q2-2024 | $24.807M ▲ | $1.4B ▲ | $1.162B ▲ | $238.046M ▼ |
| Q1-2024 | $20.721M | $899.625M | $650.265M | $249.36M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2025 | $-8.645M ▲ | $-21.126M ▲ | $29.477M ▲ | $0 ▲ | $9.16M ▲ | $-21.126M ▲ |
| Q4-2024 | $-167.367M ▼ | $-48.293M ▼ | $-29.334M ▼ | $-602K ▲ | $-79.704M ▼ | $-110.041M ▼ |
| Q3-2024 | $-36.52M ▼ | $-3.824M ▼ | $94.424M ▲ | $-641K ▲ | $90.466M ▲ | $26.494M ▲ |
| Q2-2024 | $1.459M | $8.049M | $-19.736M | $-673K | $-12.508M | $8.049M |
| Q1-2024 | $1.459M | $8.049M | $-19.736M | $-673K | $-12.508M | $8.049M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, the historical financial record shows a company that has struggled with profitability, shrinking assets, and persistent negative cash flow, leaving a thinner capital base and limited financial flexibility. At the same time, the strategic pivot into Kestrel Group represents a clean break with the past and a move toward a more modern, capital‑light, fee‑oriented specialty insurance model. The new structure, carrier partnerships, and experienced leadership create potential for a more stable and scalable earnings profile, but this remains largely unproven. From here, the key questions are whether the new model can generate steady fee income, improve cash generation, and rebuild financial strength while successfully differentiating itself in the competitive specialty insurance ecosystem.

CEO
None
Compensation Summary
(Year 2008)

CEO
None
Compensation Summary
(Year 2008)
Ratings Snapshot
Rating : D+
Institutional Ownership
Summary
Only Showing The Top 1


